nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CYP2C9—brain cancer	0.591	1	CbGaD
Rimonabant—CYP2D6—Lomustine—brain cancer	0.0731	0.218	CbGbCtD
Rimonabant—CYP1A2—Carmustine—brain cancer	0.0724	0.216	CbGbCtD
Rimonabant—CYP2D6—Hydroxyurea—brain cancer	0.0554	0.166	CbGbCtD
Rimonabant—CYP3A4—Temozolomide—brain cancer	0.0547	0.163	CbGbCtD
Rimonabant—CYP3A4—Lomustine—brain cancer	0.0465	0.139	CbGbCtD
Rimonabant—CYP1A2—Etoposide—brain cancer	0.0215	0.0641	CbGbCtD
Rimonabant—CYP3A4—Etoposide—brain cancer	0.0112	0.0336	CbGbCtD
Rimonabant—Contusion—Lomustine—brain cancer	0.00226	0.0423	CcSEcCtD
Rimonabant—Lethargy—Lomustine—brain cancer	0.00146	0.0273	CcSEcCtD
Rimonabant—Paranoia—Carmustine—brain cancer	0.00115	0.0215	CcSEcCtD
Rimonabant—Lethargy—Procarbazine—brain cancer	0.000926	0.0174	CcSEcCtD
Rimonabant—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000895	0.0422	CbGpPWpGaD
Rimonabant—Disturbance in attention—Temozolomide—brain cancer	0.000873	0.0164	CcSEcCtD
Rimonabant—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000819	0.0386	CbGpPWpGaD
Rimonabant—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000814	0.0384	CbGpPWpGaD
Rimonabant—Infection—Carboplatin—brain cancer	0.000798	0.0149	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—NTRK3—brain cancer	0.00072	0.0339	CbGpPWpGaD
Rimonabant—Infection—Lomustine—brain cancer	0.000698	0.0131	CcSEcCtD
Rimonabant—Anorexia—Lomustine—brain cancer	0.00067	0.0125	CcSEcCtD
Rimonabant—Hallucination—Procarbazine—brain cancer	0.000625	0.0117	CcSEcCtD
Rimonabant—Gastroenteritis—Temozolomide—brain cancer	0.000619	0.0116	CcSEcCtD
Rimonabant—Decreased appetite—Lomustine—brain cancer	0.000611	0.0114	CcSEcCtD
Rimonabant—Amnesia—Carmustine—brain cancer	0.000604	0.0113	CcSEcCtD
Rimonabant—Hot flush—Temozolomide—brain cancer	0.000587	0.011	CcSEcCtD
Rimonabant—Amnesia—Temozolomide—brain cancer	0.000584	0.0109	CcSEcCtD
Rimonabant—Menopausal symptoms—Temozolomide—brain cancer	0.000582	0.0109	CcSEcCtD
Rimonabant—Infestation NOS—Hydroxyurea—brain cancer	0.000541	0.0101	CcSEcCtD
Rimonabant—Infestation—Hydroxyurea—brain cancer	0.000541	0.0101	CcSEcCtD
Rimonabant—Tension—Procarbazine—brain cancer	0.000536	0.01	CcSEcCtD
Rimonabant—Nervousness—Procarbazine—brain cancer	0.000531	0.00995	CcSEcCtD
Rimonabant—Mood swings—Temozolomide—brain cancer	0.00052	0.00974	CcSEcCtD
Rimonabant—Tremor—Procarbazine—brain cancer	0.000512	0.0096	CcSEcCtD
Rimonabant—CNR1—GPCRs, Other—SMO—brain cancer	0.000508	0.0239	CbGpPWpGaD
Rimonabant—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000507	0.0239	CbGpPWpGaD
Rimonabant—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000488	0.023	CbGpPWpGaD
Rimonabant—Hallucination—Hydroxyurea—brain cancer	0.000484	0.00906	CcSEcCtD
Rimonabant—Convulsion—Procarbazine—brain cancer	0.000474	0.00887	CcSEcCtD
Rimonabant—Anxiety—Procarbazine—brain cancer	0.000464	0.00869	CcSEcCtD
Rimonabant—Dry mouth—Procarbazine—brain cancer	0.000455	0.00853	CcSEcCtD
Rimonabant—Vomiting—Lomustine—brain cancer	0.000447	0.00837	CcSEcCtD
Rimonabant—Infection—Procarbazine—brain cancer	0.000443	0.0083	CcSEcCtD
Rimonabant—Angiopathy—Hydroxyurea—brain cancer	0.000441	0.00826	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Temozolomide—brain cancer	0.000441	0.00826	CcSEcCtD
Rimonabant—Depression—Carmustine—brain cancer	0.000436	0.00818	CcSEcCtD
Rimonabant—Hyperhidrosis—Procarbazine—brain cancer	0.000431	0.00808	CcSEcCtD
Rimonabant—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00043	0.0203	CbGpPWpGaD
Rimonabant—Anorexia—Procarbazine—brain cancer	0.000425	0.00797	CcSEcCtD
Rimonabant—Infestation—Temozolomide—brain cancer	0.000423	0.00792	CcSEcCtD
Rimonabant—Infestation NOS—Temozolomide—brain cancer	0.000423	0.00792	CcSEcCtD
Rimonabant—Depression—Temozolomide—brain cancer	0.000422	0.0079	CcSEcCtD
Rimonabant—Nausea—Lomustine—brain cancer	0.000417	0.00782	CcSEcCtD
Rimonabant—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000413	0.0195	CbGpPWpGaD
Rimonabant—Insomnia—Procarbazine—brain cancer	0.000403	0.00756	CcSEcCtD
Rimonabant—Paraesthesia—Procarbazine—brain cancer	0.000401	0.00751	CcSEcCtD
Rimonabant—Sinusitis—Temozolomide—brain cancer	0.000397	0.00743	CcSEcCtD
Rimonabant—Cramp muscle—Etoposide—brain cancer	0.000395	0.00741	CcSEcCtD
Rimonabant—Hallucination—Carmustine—brain cancer	0.000391	0.00732	CcSEcCtD
Rimonabant—Hypoaesthesia—Carmustine—brain cancer	0.000391	0.00732	CcSEcCtD
Rimonabant—Decreased appetite—Procarbazine—brain cancer	0.000388	0.00727	CcSEcCtD
Rimonabant—Connective tissue disorder—Carmustine—brain cancer	0.000386	0.00723	CcSEcCtD
Rimonabant—Fatigue—Procarbazine—brain cancer	0.000385	0.00721	CcSEcCtD
Rimonabant—Hypoaesthesia—Temozolomide—brain cancer	0.000378	0.00708	CcSEcCtD
Rimonabant—Hallucination—Temozolomide—brain cancer	0.000378	0.00708	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—PTCH2—brain cancer	0.000375	0.0177	CbGpPWpGaD
Rimonabant—Connective tissue disorder—Temozolomide—brain cancer	0.000373	0.00699	CcSEcCtD
Rimonabant—Convulsion—Hydroxyurea—brain cancer	0.000367	0.00687	CcSEcCtD
Rimonabant—Gastrointestinal pain—Procarbazine—brain cancer	0.000365	0.00683	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000358	0.0067	CcSEcCtD
Rimonabant—Abdominal pain—Procarbazine—brain cancer	0.000353	0.00661	CcSEcCtD
Rimonabant—CNR1—N-cadherin signaling events—CTNNB1—brain cancer	0.00035	0.0165	CbGpPWpGaD
Rimonabant—Angiopathy—Temozolomide—brain cancer	0.000344	0.00645	CcSEcCtD
Rimonabant—Mental disorder—Carmustine—brain cancer	0.000344	0.00645	CcSEcCtD
Rimonabant—Infection—Hydroxyurea—brain cancer	0.000343	0.00643	CcSEcCtD
Rimonabant—Mediastinal disorder—Temozolomide—brain cancer	0.000342	0.00641	CcSEcCtD
Rimonabant—Malnutrition—Carmustine—brain cancer	0.000342	0.00641	CcSEcCtD
Rimonabant—Nervous system disorder—Hydroxyurea—brain cancer	0.000339	0.00634	CcSEcCtD
Rimonabant—Infestation—Etoposide—brain cancer	0.000338	0.00634	CcSEcCtD
Rimonabant—Infestation NOS—Etoposide—brain cancer	0.000338	0.00634	CcSEcCtD
Rimonabant—Skin disorder—Hydroxyurea—brain cancer	0.000335	0.00628	CcSEcCtD
Rimonabant—Mental disorder—Temozolomide—brain cancer	0.000333	0.00623	CcSEcCtD
Rimonabant—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000332	0.0156	CbGpPWpGaD
Rimonabant—Malnutrition—Temozolomide—brain cancer	0.00033	0.00619	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—OR14C36—brain cancer	0.000329	0.0155	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—OR4C12—brain cancer	0.000329	0.0155	CbGpPWpGaD
Rimonabant—Anorexia—Hydroxyurea—brain cancer	0.000329	0.00617	CcSEcCtD
Rimonabant—Tremor—Carmustine—brain cancer	0.00032	0.006	CcSEcCtD
Rimonabant—Asthenia—Procarbazine—brain cancer	0.00032	0.006	CcSEcCtD
Rimonabant—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000319	0.015	CbGpPWpGaD
Rimonabant—Pruritus—Procarbazine—brain cancer	0.000316	0.00591	CcSEcCtD
Rimonabant—Tremor—Temozolomide—brain cancer	0.00031	0.0058	CcSEcCtD
Rimonabant—Diarrhoea—Procarbazine—brain cancer	0.000305	0.00572	CcSEcCtD
Rimonabant—Hypoaesthesia—Etoposide—brain cancer	0.000302	0.00566	CcSEcCtD
Rimonabant—Decreased appetite—Hydroxyurea—brain cancer	0.0003	0.00562	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—OR4C12—brain cancer	0.000299	0.0141	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—OR14C36—brain cancer	0.000299	0.0141	CbGpPWpGaD
Rimonabant—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000298	0.00558	CcSEcCtD
Rimonabant—Fatigue—Hydroxyurea—brain cancer	0.000298	0.00558	CcSEcCtD
Rimonabant—Convulsion—Carmustine—brain cancer	0.000296	0.00555	CcSEcCtD
Rimonabant—Dizziness—Procarbazine—brain cancer	0.000295	0.00553	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—PTCH2—brain cancer	0.000295	0.0139	CbGpPWpGaD
Rimonabant—Anxiety—Carmustine—brain cancer	0.00029	0.00544	CcSEcCtD
Rimonabant—Convulsion—Temozolomide—brain cancer	0.000286	0.00536	CcSEcCtD
Rimonabant—Vomiting—Procarbazine—brain cancer	0.000284	0.00531	CcSEcCtD
Rimonabant—Rash—Procarbazine—brain cancer	0.000281	0.00527	CcSEcCtD
Rimonabant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000281	0.0133	CbGpPWpGaD
Rimonabant—Dermatitis—Procarbazine—brain cancer	0.000281	0.00527	CcSEcCtD
Rimonabant—Anxiety—Temozolomide—brain cancer	0.00028	0.00525	CcSEcCtD
Rimonabant—Headache—Procarbazine—brain cancer	0.000279	0.00524	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000279	0.00524	CcSEcCtD
Rimonabant—Infection—Carmustine—brain cancer	0.000277	0.0052	CcSEcCtD
Rimonabant—Angiopathy—Etoposide—brain cancer	0.000276	0.00516	CcSEcCtD
Rimonabant—Dry mouth—Temozolomide—brain cancer	0.000275	0.00516	CcSEcCtD
Rimonabant—Mediastinal disorder—Etoposide—brain cancer	0.000274	0.00513	CcSEcCtD
Rimonabant—Infection—Temozolomide—brain cancer	0.000268	0.00502	CcSEcCtD
Rimonabant—Anorexia—Carmustine—brain cancer	0.000266	0.00498	CcSEcCtD
Rimonabant—Nausea—Procarbazine—brain cancer	0.000265	0.00496	CcSEcCtD
Rimonabant—Nervous system disorder—Temozolomide—brain cancer	0.000265	0.00496	CcSEcCtD
Rimonabant—Skin disorder—Temozolomide—brain cancer	0.000262	0.00491	CcSEcCtD
Rimonabant—Hyperhidrosis—Temozolomide—brain cancer	0.000261	0.00489	CcSEcCtD
Rimonabant—CNR1—GPCR downstream signaling—OR14C36—brain cancer	0.000258	0.0122	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—OR4C12—brain cancer	0.000258	0.0122	CbGpPWpGaD
Rimonabant—Anorexia—Temozolomide—brain cancer	0.000257	0.00482	CcSEcCtD
Rimonabant—Muscle spasms—Etoposide—brain cancer	0.000254	0.00476	CcSEcCtD
Rimonabant—Insomnia—Carmustine—brain cancer	0.000252	0.00473	CcSEcCtD
Rimonabant—Paraesthesia—Carmustine—brain cancer	0.000251	0.0047	CcSEcCtD
Rimonabant—Asthenia—Hydroxyurea—brain cancer	0.000248	0.00464	CcSEcCtD
Rimonabant—Insomnia—Temozolomide—brain cancer	0.000244	0.00457	CcSEcCtD
Rimonabant—Decreased appetite—Carmustine—brain cancer	0.000243	0.00455	CcSEcCtD
Rimonabant—Paraesthesia—Temozolomide—brain cancer	0.000242	0.00454	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Carmustine—brain cancer	0.000241	0.00451	CcSEcCtD
Rimonabant—Diarrhoea—Hydroxyurea—brain cancer	0.000236	0.00443	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—OR14C36—brain cancer	0.000235	0.0111	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—OR4C12—brain cancer	0.000235	0.0111	CbGpPWpGaD
Rimonabant—Decreased appetite—Temozolomide—brain cancer	0.000234	0.00439	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Temozolomide—brain cancer	0.000233	0.00436	CcSEcCtD
Rimonabant—Fatigue—Temozolomide—brain cancer	0.000233	0.00436	CcSEcCtD
Rimonabant—Convulsion—Etoposide—brain cancer	0.000229	0.00429	CcSEcCtD
Rimonabant—Dizziness—Hydroxyurea—brain cancer	0.000228	0.00428	CcSEcCtD
Rimonabant—Gastrointestinal pain—Carmustine—brain cancer	0.000228	0.00428	CcSEcCtD
Rimonabant—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000228	0.0107	CbGpPWpGaD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000224	0.00419	CcSEcCtD
Rimonabant—Abdominal pain—Carmustine—brain cancer	0.000221	0.00413	CcSEcCtD
Rimonabant—Gastrointestinal pain—Temozolomide—brain cancer	0.000221	0.00413	CcSEcCtD
Rimonabant—Vomiting—Hydroxyurea—brain cancer	0.00022	0.00411	CcSEcCtD
Rimonabant—Rash—Hydroxyurea—brain cancer	0.000218	0.00408	CcSEcCtD
Rimonabant—Dermatitis—Hydroxyurea—brain cancer	0.000217	0.00407	CcSEcCtD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000217	0.0102	CbGpPWpGaD
Rimonabant—Headache—Hydroxyurea—brain cancer	0.000216	0.00405	CcSEcCtD
Rimonabant—Infection—Etoposide—brain cancer	0.000214	0.00402	CcSEcCtD
Rimonabant—Abdominal pain—Temozolomide—brain cancer	0.000213	0.00399	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—SPP1—brain cancer	0.000213	0.01	CbGpPWpGaD
Rimonabant—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000211	0.00993	CbGpPWpGaD
Rimonabant—Skin disorder—Etoposide—brain cancer	0.00021	0.00393	CcSEcCtD
Rimonabant—Hyperhidrosis—Etoposide—brain cancer	0.000209	0.00391	CcSEcCtD
Rimonabant—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000208	0.0098	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000207	0.00973	CbGpPWpGaD
Rimonabant—Anorexia—Etoposide—brain cancer	0.000206	0.00385	CcSEcCtD
Rimonabant—Nausea—Hydroxyurea—brain cancer	0.000205	0.00384	CcSEcCtD
Rimonabant—Asthenia—Carmustine—brain cancer	0.0002	0.00375	CcSEcCtD
Rimonabant—Paraesthesia—Etoposide—brain cancer	0.000194	0.00363	CcSEcCtD
Rimonabant—Asthenia—Temozolomide—brain cancer	0.000194	0.00363	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—SHH—brain cancer	0.000193	0.00912	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PTCH2—brain cancer	0.000193	0.00908	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—IRS2—brain cancer	0.000193	0.00908	CbGpPWpGaD
Rimonabant—Diarrhoea—Carmustine—brain cancer	0.000191	0.00358	CcSEcCtD
Rimonabant—Pruritus—Temozolomide—brain cancer	0.000191	0.00358	CcSEcCtD
Rimonabant—Decreased appetite—Etoposide—brain cancer	0.000188	0.00352	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Etoposide—brain cancer	0.000186	0.00349	CcSEcCtD
Rimonabant—Fatigue—Etoposide—brain cancer	0.000186	0.00349	CcSEcCtD
Rimonabant—Dizziness—Carmustine—brain cancer	0.000185	0.00346	CcSEcCtD
Rimonabant—Diarrhoea—Temozolomide—brain cancer	0.000185	0.00346	CcSEcCtD
Rimonabant—CNR2—GPCR ligand binding—PTCH1—brain cancer	0.000183	0.00864	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—SMO—brain cancer	0.000183	0.00864	CbGpPWpGaD
Rimonabant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000179	0.00841	CbGpPWpGaD
Rimonabant—Dizziness—Temozolomide—brain cancer	0.000178	0.00334	CcSEcCtD
Rimonabant—Vomiting—Carmustine—brain cancer	0.000177	0.00332	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—OR4C12—brain cancer	0.000177	0.00832	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—OR14C36—brain cancer	0.000177	0.00832	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Etoposide—brain cancer	0.000176	0.00331	CcSEcCtD
Rimonabant—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000176	0.0083	CbGpPWpGaD
Rimonabant—Rash—Carmustine—brain cancer	0.000176	0.0033	CcSEcCtD
Rimonabant—Dermatitis—Carmustine—brain cancer	0.000176	0.00329	CcSEcCtD
Rimonabant—Headache—Carmustine—brain cancer	0.000175	0.00328	CcSEcCtD
Rimonabant—Vomiting—Temozolomide—brain cancer	0.000171	0.00321	CcSEcCtD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000171	0.00805	CbGpPWpGaD
Rimonabant—Abdominal pain—Etoposide—brain cancer	0.000171	0.0032	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—APC—brain cancer	0.00017	0.00802	CbGpPWpGaD
Rimonabant—Rash—Temozolomide—brain cancer	0.00017	0.00319	CcSEcCtD
Rimonabant—Dermatitis—Temozolomide—brain cancer	0.00017	0.00318	CcSEcCtD
Rimonabant—Headache—Temozolomide—brain cancer	0.000169	0.00317	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—ABR—brain cancer	0.000167	0.00785	CbGpPWpGaD
Rimonabant—Nausea—Carmustine—brain cancer	0.000166	0.00311	CcSEcCtD
Rimonabant—Nausea—Temozolomide—brain cancer	0.00016	0.003	CcSEcCtD
Rimonabant—Asthenia—Etoposide—brain cancer	0.000155	0.0029	CcSEcCtD
Rimonabant—Pruritus—Etoposide—brain cancer	0.000153	0.00286	CcSEcCtD
Rimonabant—CNR1—GPCR ligand binding—SHH—brain cancer	0.000152	0.00715	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PTCH2—brain cancer	0.000151	0.00713	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—ABR—brain cancer	0.000151	0.00713	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—DTX2—brain cancer	0.00015	0.00708	CbGpPWpGaD
Rimonabant—Diarrhoea—Etoposide—brain cancer	0.000148	0.00277	CcSEcCtD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000145	0.00682	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—SMO—brain cancer	0.000144	0.00678	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—PTCH1—brain cancer	0.000144	0.00678	CbGpPWpGaD
Rimonabant—Dizziness—Etoposide—brain cancer	0.000143	0.00267	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—OR4C12—brain cancer	0.000139	0.00653	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—OR14C36—brain cancer	0.000139	0.00653	CbGpPWpGaD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000138	0.00649	CbGpPWpGaD
Rimonabant—Vomiting—Etoposide—brain cancer	0.000137	0.00257	CcSEcCtD
Rimonabant—Rash—Etoposide—brain cancer	0.000136	0.00255	CcSEcCtD
Rimonabant—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000136	0.00641	CbGpPWpGaD
Rimonabant—Dermatitis—Etoposide—brain cancer	0.000136	0.00255	CcSEcCtD
Rimonabant—Headache—Etoposide—brain cancer	0.000135	0.00253	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—RELA—brain cancer	0.000133	0.00627	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—ABR—brain cancer	0.000131	0.00616	CbGpPWpGaD
Rimonabant—Nausea—Etoposide—brain cancer	0.000128	0.0024	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—ABR—brain cancer	0.000119	0.00559	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—DTX2—brain cancer	0.000118	0.00555	CbGpPWpGaD
Rimonabant—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000117	0.00551	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—CTNNB1—brain cancer	0.000116	0.00545	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTCH2—brain cancer	0.000114	0.00536	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000112	0.00526	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HES5—brain cancer	0.00011	0.0052	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STRADA—brain cancer	0.000107	0.00504	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—TRPC6—brain cancer	0.000105	0.00497	CbGpPWpGaD
Rimonabant—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000104	0.00489	CbGpPWpGaD
Rimonabant—CNR1—BDNF signaling pathway—STAT3—brain cancer	0.000101	0.00475	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—SHH—brain cancer	9.93e-05	0.00468	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—TRPC6—brain cancer	9.57e-05	0.00451	CbGpPWpGaD
Rimonabant—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.53e-05	0.00449	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—SMO—brain cancer	9.41e-05	0.00443	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PTCH1—brain cancer	9.41e-05	0.00443	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.07e-05	0.00428	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.95e-05	0.00422	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ABR—brain cancer	8.93e-05	0.00421	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTCH2—brain cancer	8.93e-05	0.00421	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HES5—brain cancer	8.65e-05	0.00408	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GLI2—brain cancer	8.63e-05	0.00407	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STRADA—brain cancer	8.4e-05	0.00396	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—TRPC6—brain cancer	8.27e-05	0.0039	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GLI1—brain cancer	8.11e-05	0.00382	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.93e-05	0.00374	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—VAV1—brain cancer	7.9e-05	0.00372	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—SHH—brain cancer	7.79e-05	0.00367	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SUFU—brain cancer	7.69e-05	0.00362	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.69e-05	0.00362	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.58e-05	0.00357	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—TRPC6—brain cancer	7.51e-05	0.00354	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—GFAP—brain cancer	7.42e-05	0.0035	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—SMO—brain cancer	7.38e-05	0.00348	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PTCH1—brain cancer	7.38e-05	0.00348	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—VAV1—brain cancer	7.17e-05	0.00338	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HEY1—brain cancer	7.03e-05	0.00331	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ABR—brain cancer	7.01e-05	0.0033	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—DLL1—brain cancer	6.9e-05	0.00325	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GLI2—brain cancer	6.77e-05	0.00319	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GLI1—brain cancer	6.36e-05	0.003	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—VAV1—brain cancer	6.2e-05	0.00292	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SUFU—brain cancer	6.03e-05	0.00284	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.93e-05	0.0028	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SHH—brain cancer	5.86e-05	0.00276	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.85e-05	0.00276	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GFAP—brain cancer	5.82e-05	0.00274	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TRPC6—brain cancer	5.65e-05	0.00266	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—VAV1—brain cancer	5.63e-05	0.00265	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SMO—brain cancer	5.56e-05	0.00262	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTCH1—brain cancer	5.56e-05	0.00262	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HEY1—brain cancer	5.52e-05	0.0026	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—DLL1—brain cancer	5.41e-05	0.00255	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CG—brain cancer	5.01e-05	0.00236	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SHH—brain cancer	4.6e-05	0.00217	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.57e-05	0.00216	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CG—brain cancer	4.55e-05	0.00215	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH2—brain cancer	4.44e-05	0.00209	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TRPC6—brain cancer	4.44e-05	0.00209	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SMO—brain cancer	4.36e-05	0.00206	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTCH1—brain cancer	4.36e-05	0.00206	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VAV1—brain cancer	4.24e-05	0.002	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.12e-05	0.00194	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CG—brain cancer	3.93e-05	0.00185	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HES1—brain cancer	3.64e-05	0.00172	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CG—brain cancer	3.57e-05	0.00168	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—IL2—brain cancer	3.53e-05	0.00166	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.5e-05	0.00165	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH2—brain cancer	3.49e-05	0.00164	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PDGFRA—brain cancer	3.47e-05	0.00163	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SPP1—brain cancer	3.37e-05	0.00159	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VAV1—brain cancer	3.32e-05	0.00157	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.22e-05	0.00152	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL2—brain cancer	3.2e-05	0.00151	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.15e-05	0.00148	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.15e-05	0.00148	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IRS2—brain cancer	3.05e-05	0.00144	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.95e-05	0.00139	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HES1—brain cancer	2.86e-05	0.00135	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—IL2—brain cancer	2.77e-05	0.0013	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PDGFRA—brain cancer	2.72e-05	0.00128	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CG—brain cancer	2.69e-05	0.00127	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—APC—brain cancer	2.69e-05	0.00127	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SPP1—brain cancer	2.64e-05	0.00125	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.53e-05	0.00119	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL2—brain cancer	2.51e-05	0.00118	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EGFR—brain cancer	2.45e-05	0.00115	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IRS2—brain cancer	2.39e-05	0.00113	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.16e-05	0.00102	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APC—brain cancer	2.11e-05	0.000995	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CG—brain cancer	2.11e-05	0.000995	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RELA—brain cancer	2.1e-05	0.00099	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ERBB2—brain cancer	2.09e-05	0.000984	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—brain cancer	1.92e-05	0.000906	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL2—brain cancer	1.89e-05	0.000892	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCND1—brain cancer	1.85e-05	0.00087	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CTNNB1—brain cancer	1.83e-05	0.000861	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RELA—brain cancer	1.65e-05	0.000777	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ERBB2—brain cancer	1.64e-05	0.000772	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—brain cancer	1.61e-05	0.000758	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STAT3—brain cancer	1.59e-05	0.000751	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP2C9—brain cancer	1.55e-05	0.000731	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL2—brain cancer	1.49e-05	0.0007	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—brain cancer	1.48e-05	0.000698	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—brain cancer	1.45e-05	0.000682	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—brain cancer	1.45e-05	0.000682	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CTNNB1—brain cancer	1.43e-05	0.000676	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BSG—brain cancer	1.32e-05	0.000622	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2C9—brain cancer	1.31e-05	0.00062	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BSG—brain cancer	1.31e-05	0.000616	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—brain cancer	1.26e-05	0.000595	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—brain cancer	1.25e-05	0.000589	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—brain cancer	1.22e-05	0.000573	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—brain cancer	1.16e-05	0.000547	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—brain cancer	1.14e-05	0.000535	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—IDH1—brain cancer	1.13e-05	0.000535	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—IDH1—brain cancer	1.12e-05	0.00053	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BSG—brain cancer	1.12e-05	0.000527	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2C9—brain cancer	1.01e-05	0.000478	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—IDH1—brain cancer	9.61e-06	0.000453	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—brain cancer	9.54e-06	0.000449	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.16e-06	0.000432	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO2—brain cancer	8.97e-06	0.000423	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO2—brain cancer	8.89e-06	0.000419	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BSG—brain cancer	8.63e-06	0.000407	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.83e-06	0.000369	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO2—brain cancer	7.6e-06	0.000358	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—IDH1—brain cancer	7.42e-06	0.00035	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO2—brain cancer	5.86e-06	0.000276	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—brain cancer	4.11e-06	0.000194	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—brain cancer	4.08e-06	0.000192	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—brain cancer	3.49e-06	0.000164	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—brain cancer	2.69e-06	0.000127	CbGpPWpGaD
